Alnylam, gene-silencing and biotech in 2020: the pharmaphorum podcast

from pharmaphorum Podcast · host pharmaphorum

Anlnylam’s Brendan Martin joined the pharmaphorum podcast for episode 23 to talk about his company’s work in gene-silencing and how it could offer a route to target the current coronavirus pandemic.

Episode metadata supplied by the publisher feed · Published Aug 27, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Alnylam, gene-silencing and biotech in 2020: the pharmaphorum podcast

0:00 19:02

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of pharmaphorum Podcast?

This episode is 19 minutes long.

When was this pharmaphorum Podcast episode published?

This episode was published on August 27, 2020.

Can I download this pharmaphorum Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!